Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aurinia, AGTC, Jazz, MC2, Redhill.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptvac, Akcea, Almirall, Altimmune, Ampio, Astellas, ATAI, Bavarian Nordic, Biofourmis, Chugai, Covaxx, Cullinan, Daiichi Sankyo, ERC, Evotec, Fibrogenesis, Innovation, Ionis, Jaguar, Kiadis, Liminal, Nouscom, Novartis, Oragenics, Q Biomed, Qualigen, Scynexis, Therapeutics Solutions, Xbiotech, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascentage, Azurrx, Axogen, Belite, Genentech, Horizon, Regulus, Scynexis, Springworks, Talaris, Terns, TG, Transgene, Valneva.

Biopharmas raising money in public or private financings, including: 4D, Alx, CASI, Cytokinetics, Eikonoklastes, Genocea, GT Biopharma, Kiniksa, Olema, Resverlogix, Vesigen.

New hires and promotions in the biopharma industry, including: Adaptate, Aztherapies, Biogen, Cellectis, Dynavax, Generation, Replimune.

Quarterly snapshots from biopharma companies with marketed products, including: Biogen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akebia, Algernon, Ascletis, Astrazeneca, Bioarctic, Biogen, Biontech, Calcimedica, Celltrion, China National, Dynavax, Eisai, Glaxosmithkline, Heron, Medicago, Moderna, Neurorx, Pfizer, Phasebio, Relief, Ribomic, Rigel, Santen, Synairgen.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astellas, Beigene, Deciphera, Generex, Immuron, IMV, Puma, Redhill, Shanghai Fosun, Sorrento, Specialised, Tetra.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Arctic Vision, Beigene, Eisai, Exalys, Sosei.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Acepodia, Anheart, Applied DNA Sciences, Arch Biopartners, Aslan, Astrazeneca, Basilea, Bio-Thera Solutions, Bold, Bridge, BSP, Can-Fite, Cellink, CNS, Emergent Biosolutions, Eureka, Hao Tian Development, Humanigen, Immuneoncia, Immuron, JW Therapeutics (Shanghai), Kalytera, Kugelmeiers, Marinomed, Mateon, Moleculin, Newg Lab, Novartis, Octapharma, Ose Immunotherapeutics, Pascal, Pfizer, Pharmaceutics International, Pharmapark, Promethera, Recce, Rensselaer Polytechnic Institute, Samsung Biologics, Sterling Pharma USA, Takis, Tevogen, TLC, Tonix, Twist, Vitro Diagnostics, Zyus Life Sciences.